MedPath

VERGE GENOMICS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study of VRG50635 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
First Posted Date
2024-02-29
Last Posted Date
2024-12-12
Lead Sponsor
Verge Genomics
Target Recruit Count
22
Registration Number
NCT06286475
Locations
🇺🇸

Lincoln Celerion Inc.,, Lincoln, Nebraska, United States

A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Phase 1
Active, not recruiting
Conditions
Amyotrophic Lateral Sclerosis
Interventions
First Posted Date
2024-01-22
Last Posted Date
2024-12-12
Lead Sponsor
Verge Genomics
Target Recruit Count
54
Registration Number
NCT06215755
Locations
🇨🇦

The Neuro - Montréal Neurological Institute-Hospital, Montreal, Quebec, Canada

🇧🇪

UZ Leuven, Leuven, Flemish Brabant, Belgium

🇳🇱

University Medical Center Utrecht, Utrecht, Netherlands

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath